Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's l...
Q1 2026
May 14, 2026
FY 2025
Mar 18, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 19, 2025